These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27244783)

  • 1. Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case.
    Polat İ; Yiş U; Karaoğlu P; Ayanoğlu M; Öztürk T; Güleryüz H; Kurul SH
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
    Thulasirajah S; Pohl D; Davila-Acosta J; Venkateswaran S
    Neuropediatrics; 2016 Aug; 47(4):245-52. PubMed ID: 27128728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.
    Wong YYM; Hacohen Y; Armangue T; Wassmer E; Verhelst H; Hemingway C; van Pelt ED; Catsman-Berrevoets CE; Hintzen RQ; Deiva K; Lim MJ; Rostásy K; Neuteboom RF
    Eur J Neurol; 2018 May; 25(5):782-786. PubMed ID: 29443442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
    Baumann M; Hennes EM; Schanda K; Karenfort M; Kornek B; Seidl R; Diepold K; Lauffer H; Marquardt I; Strautmanis J; Syrbe S; Vieker S; Höftberger R; Reindl M; Rostásy K
    Mult Scler; 2016 Dec; 22(14):1821-1829. PubMed ID: 26869530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy.
    Azumagawa K; Nomura S; Shigeri Y; Jones LS; Sato DK; Nakashima I; Kashiwagi M; Tanabe T; Shimakawa S; Nakajima H; Tamai H
    Brain Dev; 2016 Aug; 38(7):690-3. PubMed ID: 26922251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders.
    Konuskan B; Yildirim M; Gocmen R; Okur TD; Polat I; Kilic H; Saltik S; Ozturk Z; Gucuyener K; Altunbasak S; Celik T; Kose G; Yilmaz A; Komur M; Kayilioglu H; Anlar B
    Mult Scler Relat Disord; 2018 Nov; 26():1-7. PubMed ID: 30212767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.
    Ramanathan S; Mohammad S; Tantsis E; Nguyen TK; Merheb V; Fung VSC; White OB; Broadley S; Lechner-Scott J; Vucic S; Henderson APD; Barnett MH; Reddel SW; Brilot F; Dale RC;
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):127-137. PubMed ID: 29142145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
    Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
    Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOG Spectrum Disorders and Role of MOG-Antibodies in Clinical Practice.
    Hennes EM; Baumann M; Lechner C; Rostásy K
    Neuropediatrics; 2018 Feb; 49(1):3-11. PubMed ID: 28859212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset acute disseminated encephalomyelitis followed by optic neuritis without anti-myelin oligodendrocyte glycoprotein antibodies: a biopsied case report.
    Mori M; Sakai K; Tada Y; Nozaki I; Usui Y; Ichinose T; Tanaka S; Takahashi T; Nakada M; Yamada M
    Neurol Sci; 2021 Nov; 42(11):4731-4735. PubMed ID: 34170431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.
    Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R; Muñoz-Batista M; Ariño H; González-Álvarez V; Felipe-Rucián A; Jesús Martínez-González M; Cantarín-Extremera V; Concepción Miranda-Herrero M; Monge-Galindo L; Tomás-Vila M; Miravet E; Málaga I; Arrambide G; Auger C; Tintoré M; Montalban X; Vanderver A; Graus F; Saiz A; Dalmau J;
    Lancet Neurol; 2020 Mar; 19(3):234-246. PubMed ID: 32057303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report.
    Nakamura Y; Nakajima H; Tani H; Hosokawa T; Ishida S; Kimura F; Kaneko K; Takahashi T; Nakashima I
    BMC Neurol; 2017 Apr; 17(1):76. PubMed ID: 28420330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures.
    Gutman JM; Kupersmith M; Galetta S; Kister I
    J Neurol Sci; 2018 Apr; 387():170-173. PubMed ID: 29571858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
    Hennes EM; Baumann M; Schanda K; Anlar B; Bajer-Kornek B; Blaschek A; Brantner-Inthaler S; Diepold K; Eisenkölbl A; Gotwald T; Kuchukhidze G; Gruber-Sedlmayr U; Häusler M; Höftberger R; Karenfort M; Klein A; Koch J; Kraus V; Lechner C; Leiz S; Leypoldt F; Mader S; Marquard K; Poggenburg I; Pohl D; Pritsch M; Raucherzauner M; Schimmel M; Thiels C; Tibussek D; Vieker S; Zeches C; Berger T; Reindl M; Rostásy K;
    Neurology; 2017 Aug; 89(9):900-908. PubMed ID: 28768844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent presence of the anti-myelin oligodendrocyte glycoprotein autoantibody in a pediatric case of acute disseminated encephalomyelitis followed by optic neuritis.
    Miyauchi A; Monden Y; Watanabe M; Sugie H; Morita M; Kezuka T; Momoi M; Yamagata T
    Neuropediatrics; 2014 Jun; 45(3):196-9. PubMed ID: 24610298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
    Baumann M; Sahin K; Lechner C; Hennes EM; Schanda K; Mader S; Karenfort M; Selch C; Häusler M; Eisenkölbl A; Salandin M; Gruber-Sedlmayr U; Blaschek A; Kraus V; Leiz S; Finsterwalder J; Gotwald T; Kuchukhidze G; Berger T; Reindl M; Rostásy K
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):265-72. PubMed ID: 25121570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab was effective for acute disseminated encephalomyelitis followed by recurrent optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies.
    Nagashima M; Osaka H; Ikeda T; Matsumoto A; Miyauchi A; Kaneko K; Nakashima I; Nakano Y; Wakabayashi K; Monden Y; Yamagata T
    Brain Dev; 2018 Aug; 40(7):607-611. PubMed ID: 29661590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.